Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Current Assets: 2014-2025

Historic Current Assets for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $1.1 billion.

  • Surgery Partners' Current Assets rose 641.05% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year increase of 1464.63%. This contributed to the annual value of $1.1 billion for FY2024, which is 2507.26% up from last year.
  • As of Q3 2025, Surgery Partners' Current Assets stood at $1.1 billion, which was up 641.05% from $1.1 billion recorded in Q2 2025.
  • Surgery Partners' Current Assets' 5-year high stood at $1.1 billion during Q4 2024, with a 5-year trough of $738.3 million in Q3 2022.
  • Its 5-year average for Current Assets is $944.2 million, with a median of $937.0 million in 2022.
  • As far as peak fluctuations go, Surgery Partners' Current Assets surged by 6560.36% in 2021, and later tumbled by 1726.31% in 2022.
  • Surgery Partners' Current Assets (Quarter) stood at $946.1 million in 2021, then dropped by 2.65% to $921.0 million in 2022, then fell by 2.82% to $895.0 million in 2023, then increased by 25.07% to $1.1 billion in 2024, then dropped by 1.54% to $1.1 billion in 2025.
  • Its Current Assets stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.